• linkedin
  • Increase Font
  • Sharebar

    Research offers insights to success in macular hole surgery


    Japanese report

    As reported by Japanese surgeons [Yamashita, et al. Retina. 2014;34(7):1367-1375], Optical coherence tomography can monitor the status of the macular hole and determine the need to continue prone positioning, but their use of this approach involved daily follow-up.

    “Most macular holes close in 24 to 48 hours, and in this study, a closure rate of 96.2% was achieved with a mean prone positioning duration of 42 hours,” Dr. Thompson said. “However, there are some macular holes that can take seven days to close.”

    Results of a Cochrane review of three randomized, controlled trials evaluating prone positioning support its consideration in eyes with large macular holes [Cochrane Database of Systematic Reviews 2001, Issue 12. Art no.: CD008228]. The analyses showed prone positioning had no significant benefit overall, but it was associated with a higher closure rate for holes >400 µm.

    Dr. Thompson also noted that vitrectomy is more cost-effective than ocriplasmin (Jetrea, ThromboGenics) for treating macular holes, and the reason relates to the high cost of the pharmacologic agent. A cost benefit analysis comparing the two techniques calculated that the cost per quality-adjusted life year ranged from $5,444 to $7,442 for vitrectomy and from $8,159 to $10,244 for ocriplasmin [Chang JS, Smiddy WE. Ophthalmology. 2014;121(9):1720-1726].


    John T. Thompson, MD

    E: [email protected]

    This article is based on a presentation given by Dr. Thompson at the Retina Subspecialty Day, held prior to 2016 American Academy of Ophthalmology meeting. Dr. Thompson has no financial interests relevant to the material discussed.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow

    var script= ' ';